Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HeraMED Ltd. ( (AU:HMD) ) has provided an update.
HeraMED Limited has called an Extraordinary General Meeting for 26 March 2026 in Hawthorn East, Victoria, and will provide the Notice of Meeting primarily via electronic distribution in line with updated provisions of the Corporations Act. The company is encouraging shareholders to participate either in person or by lodging proxy votes online, by post or by email, with all resolutions to be decided by poll.
Shareholders are also being reminded of their rights to elect how they receive company documents, including the option to receive communications electronically, in hard copy, or to opt out of certain reports. This move toward digital communication is positioned as a more efficient and sustainable way to engage investors, while ensuring that those who prefer physical documents can update their preferences through the share registry portal.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.04 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Limited is an ASX-listed company (ASX:HMD) operating in the healthcare technology space, with a focus on digital solutions for pregnancy monitoring and maternal health. The company targets both clinical providers and expectant mothers, aiming to improve care delivery and patient engagement through connected medical devices and supporting software platforms.
Average Trading Volume: 879,237
Technical Sentiment Signal: Buy
Current Market Cap: A$40.09M
Find detailed analytics on HMD stock on TipRanks’ Stock Analysis page.